Risperdal is a prescription antipsychotic drug. It is mainly used to treat mental disorders such as bipolar disorder and schizophrenia. Risperdal was originally developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. It was approved by the FDA in December of 1993. Annual sales of Risperdal peaked at over $4.5 billion in 2007. Because Janssen’s patent has since expired, many generic versions are now available and Johnson & Johnson’s profits have declined. Johnson & Johnson has been involved in multiple lawsuits regarding Risperdal Gynecomastia and other side effects patients have suffered from taking Risperdal. .
Common side effects to Risperdal include fatigue, abdominal pain, or insomnia. Some severe side effects of Risperdal include diabetes, bone loss, pancreatitis, and seizures.
Beginning in 1999, numerous male patients have reported developing gynecomastia, excessive growth of breast tissue, as a result of taking Risperdal. It is believed that Risperdal gynecomastia develops because Risperdal works to block dopamine. As a result, the pituitary gland may release prolactin. Prolactin is a hormone that stimulates milk production and breast development in women. In women, excess levels of prolactin can cause spontaneous production of milk. In men, prolactin can cause gynecomastia.
Physical symptoms of Risperdal Gynecomastia include: pain, tenderness, swelling, and nipple discharge.
Risperdal gynecomastia often requires surgery to correct. Liposuction may be used to remove breast tissue in mild to moderate cases of Risperdal gynecomastia. In more severe cases, the patient may require a breast reduction procedure or mastectomy, or the surgical removal of breast tissue and excess breast skin.
Risperdal Gynecomastia typically does not pose serious health complications, however it often requires surgery to correct. In mild cases, liposuction may be used to remove the breast tissue. In severe cases, a mastectomy may be necessary for correction. The condition is both psychologically and emotionally damaging to the patients.